We aimed to determine the effect of elevated BMI over time on the progression to type 1 diabetes in youth.
accommodate irregular timing of BMI assessment in relation to time to diabetes or censoring (for calculation of ceBMI, see Supplementary Data). For individuals who progressed to diabetes, the last BMI used was $6 months prior to diagnosis date.
Statistical Considerations
Pearson x 2 tests, Fisher exact tests, Wilcoxon rank-sum tests, Kruskal-Wallis tests, and nonparametric Spearman rank correlation tests were used as appropriate. Analyses of BMI were based on relevant Centers for Disease Control and Prevention cutoffs (www.cdc.gov/ nccdphp/dnpao/growthcharts/resources/ sas.htm). ceBMI was analyzed as both a continuous measure and a dichotomized measure. ceBMI $0 indicated that an individual's average BMI was $85th age-and sex-adjusted percentile during the observation period.
The primary outcome was time to type 1 diabetes (i.e., time from first BMI evaluation to date of diagnosis). Those not diagnosed with type 1 diabetes were censored at their last follow-up or enrollment in a prevention trial. Kaplan-Meier methods assessed distribution differences in the time to type 1 diabetes among groups, and Cox proportional hazards models evaluated the influence of continuous and categorical variables. Assumptions for proportionality of hazards were tested. All time-toevent analyses were adjusted for age, sex, and antibody number confirmed at screening (single vs. multiple). Additional adjustment for the presence of the highestrisk HLA genotype (i.e., DR3-DQ2/DR4-DQ8) did not alter significance of the results. Recursive partitioning analysis was used to identify critical cut points for ceBMI and age at first BMI evaluation for influence on diabetes development and risk stratification of time-to-event (12) (rpart package in R).
Inferential tests were two-sided. Any P values ,0.05 (0.1 for interaction terms) were considered significant. All analyses were conducted in R (version 3.1.2; Windows; Microsoft).
RESULTS
We analyzed a total of 1,117 pediatric subjects of the PTP cohort between the ages of 2 and 18 years (median: Age at baseline was a significant independent risk factor for type 1 diabetes progression (HR: 0.94; P 5 0.0006), adjusted for ceBMI, sex, and antibody status. A significant interaction between age and sex together with ceBMI in relation to time to diabetes (P 5 0.072) triggered investigation of age-and sex-specific strata. By recursive partitioning algorithms, we first identified 12 years as the age cut point that best discriminated risk for type 1 diabetes progression for the combined cohort and for males or females independently. Recursive partitioning analysis as well as multivariable model-based diagnostics identified cut points for ceBMI that best differentiated risk for disease progression (ceBMI diabetes risk threshold). The ceBMI diabetes risk threshold was lower in children ,12 years, regardless of sex (21.4 kg/m 2 ), than in older children (4.6 kg/m 2 ). That is, the increase in type 1 diabetes risk occurs at lower levels of sustained excess BMI in younger children.
Males overall had a higher ceBMI diabetes risk threshold influencing progression to type 1 diabetes than females, suggesting an increased sensitivity to BMI in female subjects. Males $12 years of age were least affected by ceBMI and had a risk threshold (5 kg/m 2 ) much higher than the threshold defining overweight/obese. In contrast, females ,12 years old appeared to be most influenced by body weight, as the ceBMI risk threshold was 21.35 kg/m 2 , suggesting that BMI percentiles below the overweight/obese threshold still increase type 1 diabetes risk in this subgroup (Fig. 1) .
CONCLUSIONS
Our study is the first to apply ceBMI methodology to type 1 diabetes, and results support that sustained elevation of BMI is associated with type 1 diabetes progression, with effects varying by sex and age. Older age diluted the effect of elevated BMI on type 1 diabetes progression as seen by a lower ceBMI diabetes risk threshold in individuals ,12 years old compared with those $12 years old. This age-dependent effect of sustained excess BMI on type 1 diabetes progression is present in both sexes, but females were more sensitive to the effect of elevated BMI.
These findings lend insight into prior studies that reported inconsistent results of the effects of BMI on type 1 diabetes risk (2) (3) (4) (5) . Beyond incorporation of longitudinal data, ceBMI measurement offers the additional advantage of an unrestricted upper limit compared with BMI percentile and may offer greater resolution than BMI Z-score.
Limitations include the lack of Tanner staging and sex hormone measurements that could elucidate mechanisms of the identified age-and sex-specific ceBMI diabetes risk thresholds. Our study was not designed to specifically address the effects of acute changes in BMI on disease onset, and the small number of diabetes events in some age and sex strata further hindered this ability. Finally, we investigated an at-risk cohort of autoantibody-positive relatives of patients with type 1 diabetes; although this cohort was heterogeneous, the results may not be broadly applicable to the general population.
Our results indicate that sustained elevation of BMI is associated with increased progression to type 1 diabetes in an at-risk pediatric population and that the BMI 85th percentile may not appropriately differentiate this risk for all pediatric subjects. Our data suggest that lifestyle modifications may delay disease onset in an at-risk population and suggest Figure 1 -Effect of ceBMI on type 1 diabetes risk comparing traditional overweight/obese ceBMI definitions to age-and sex-specific ceBMI diabetes risk thresholds. Proportion type 1 diabetes-free pediatric subjects of the PTP cohort according to age ($12 vs. ,12 years old) and sex strata (males vs. females). A, C, E, and G: Assessment of overweight/obese threshold based on the 85th percentile for age-and sex-adjusted BMI. Dotted lines indicate ceBMI $0 (overweight/obese); solid gray indicates ceBMI ,0 (nonoverweight/obese). B, D, F, and H: Assessment of ceBMI diabetes risk thresholds identified by recursive partitioning. Dotted lines indicate greater than or equal to age-and sex-specific ceBMI diabetes risk threshold; solid gray indicates less than age-and sex-specific ceBMI diabetes risk threshold. All models adjusted for antibody number (single vs. multiple).
age-and sex-specific ceBMI thresholds to implement such changes. 
